These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25186790)

  • 1. Outcomes of ceftriaxone use compared to standard of therapy in methicillin susceptible staphylococcal aureus (MSSA) bloodstream infections.
    Patel UC; McKissic EL; Kasper D; Lentino JR; Pachucki CT; Lee T; Lopansri BK
    Int J Clin Pharm; 2014 Dec; 36(6):1282-9. PubMed ID: 25186790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia.
    Yetmar ZA; Khodadadi RB; Go JR; Chesdachai S; Abu Saleh OM
    Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):423-430. PubMed ID: 36800065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible
    Ganguly A; de la Flor C; Alvarez K; Brown LS; Mang NS; Smartt J; King H; Perl TM; Filizola H; Bhavan KP
    Ann Pharmacother; 2023 Apr; 57(4):425-431. PubMed ID: 35942602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
    Wong D; Wong T; Romney M; Leung V
    BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
    Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
    Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible
    Barber KE; Cramer RA; Bell AM; Wagner JL; Stover KR
    Case Rep Infect Dis; 2021; 2021():8884685. PubMed ID: 33986964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Cefazolin Versus Ceftriaxone for the Treatment of Methicillin-Susceptible
    Carr DR; Stiefel U; Bonomo RA; Burant CJ; Sims SV
    Open Forum Infect Dis; 2018 May; 5(5):ofy089. PubMed ID: 30568987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
    Martínez-Aguilar G; Hammerman WA; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2003 Jul; 22(7):593-8. PubMed ID: 12867833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible
    Kufel WD; Zagoria Z; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
    Ann Pharmacother; 2024 Apr; 58(4):360-365. PubMed ID: 37542415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
    Miller MA; Fish DN; Barber GR; Barron MA; Goolsby TA; Moine P; Mueller SW
    J Microbiol Immunol Infect; 2020 Apr; 53(2):321-327. PubMed ID: 30190234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
    Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN
    BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study.
    Oh DH; Kim JJ; Kim J; Seong H; Lee SJ; Kim YC; Kim EJ; Jung IY; Jeong WY; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    BMC Infect Dis; 2018 Jan; 18(1):60. PubMed ID: 29378565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureus.
    Wieland BW; Marcantoni JR; Bommarito KM; Warren DK; Marschall J
    Clin Infect Dis; 2012 Mar; 54(5):585-90. PubMed ID: 22144536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone.
    Winans SA; Luce AM; Hasbun R
    Infection; 2013 Aug; 41(4):769-74. PubMed ID: 23686435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus.
    Harbarth S; Rutschmann O; Sudre P; Pittet D
    Arch Intern Med; 1998 Jan; 158(2):182-9. PubMed ID: 9448557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
    Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
    Trials; 2018 May; 19(1):297. PubMed ID: 29843781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
    Wong D; Wong T; Romney M; Leung V
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():27. PubMed ID: 27112143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa.
    Osmon S; Ward S; Fraser VJ; Kollef MH
    Chest; 2004 Feb; 125(2):607-16. PubMed ID: 14769745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial.
    Cheng MP; Lawandi A; Butler-Laporte G; De l'Étoile-Morel S; Paquette K; Lee TC
    Clin Infect Dis; 2021 May; 72(9):e196-e203. PubMed ID: 32667982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.